Methicillin-resistant staphylococcus aureus nosocomial infection has a distinct epidemiological position and acts as a marker for overall hospital-acquired infection trends

• Published in: Scientific reports Vol. 12; no. 1; pp. 17007 - 10
• Main Authors: Samia, Noelle I., Robicsek, Ari, Heesterbeek, Hans, Peterson, Lance R.
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 11.10.2022; Nature Publishing Group; Nature Portfolio
• Subjects: 639/705/531; 692/308/174; 692/699/255; Biomarkers; COVID-19; COVID-19 - epidemiology; Cross Infection - epidemiology; Cross Infection - prevention & control; Drug resistance; Epidemiology; Health care; Hospitals; Humanities and Social Sciences; Humans; Methicillin; Methicillin-Resistant Staphylococcus aureus; multidisciplinary; Nonlinear systems; Nosocomial infection; Nosocomial infections; Pandemics; Pathogens; Patients; Public health; Science; Science (multidisciplinary); Staphylococcal Infections - epidemiology; Staphylococcal Infections - prevention & control; Staphylococcus aureus; Staphylococcus infections

An ongoing healthcare debate is whether controlling hospital-acquired infection (HAI) from methicillin-resistant Staphylococcus aureus (MRSA) will result in lowering the global HAI rate, or if MRSA will simply be replaced by another pathogen and there will be no change in overall disease burden. Wit...